Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.0%, driven by Thermo Fisher Scientific declining 2.4%. On the other hand Stevanato Group is actually up 9.0%. Over the past 12 months, the industry was up 3.4%. Looking forward, earnings are forecast to grow by 17% annually.
Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 27 Mar 2024 | US$735.1b | US$142.1b | US$12.8b | 43.8x | 57.4x | 5.2x |
Fri, 23 Feb 2024 | US$720.2b | US$142.3b | US$12.5b | 42.5x | 57.4x | 5.1x |
Sun, 21 Jan 2024 | US$687.1b | US$153.8b | US$14.2b | 35.9x | 48.5x | 4.5x |
Tue, 19 Dec 2023 | US$684.6b | US$153.7b | US$14.2b | 37x | 48.1x | 4.5x |
Thu, 16 Nov 2023 | US$603.3b | US$153.9b | US$13.9b | 33.7x | 43.4x | 3.9x |
Sat, 14 Oct 2023 | US$629.3b | US$154.6b | US$11.2b | 33.2x | 56.2x | 4.1x |
Mon, 11 Sep 2023 | US$687.1b | US$154.6b | US$11.2b | 31.6x | 61.3x | 4.4x |
Wed, 09 Aug 2023 | US$733.4b | US$154.6b | US$11.2b | 30.3x | 65.5x | 4.7x |
Fri, 07 Jul 2023 | US$687.8b | US$152.4b | US$12.5b | 29.6x | 55x | 4.5x |
Sun, 04 Jun 2023 | US$683.1b | US$152.4b | US$12.5b | 29.1x | 54.6x | 4.5x |
Tue, 02 May 2023 | US$701.9b | US$152.9b | US$9.4b | 29.5x | 74.4x | 4.6x |
Thu, 30 Mar 2023 | US$708.3b | US$154.5b | US$10.8b | 26.3x | 65.5x | 4.6x |
Sat, 25 Feb 2023 | US$712.1b | US$154.3b | US$11.0b | 30.1x | 65x | 4.6x |
Mon, 23 Jan 2023 | US$769.6b | US$155.3b | US$8.5b | 30.9x | 90.3x | 5x |
Wed, 21 Dec 2022 | US$731.5b | US$155.2b | US$8.8b | 28x | 83.3x | 4.7x |
Fri, 18 Nov 2022 | US$745.1b | US$154.9b | US$8.8b | 27.5x | 84.2x | 4.8x |
Sun, 16 Oct 2022 | US$693.0b | US$152.5b | US$17.0b | 23.6x | 40.7x | 4.5x |
Tue, 13 Sep 2022 | US$811.0b | US$152.3b | US$17.3b | 30.9x | 46.8x | 5.3x |
Thu, 11 Aug 2022 | US$836.4b | US$151.9b | US$18.0b | 33.6x | 46.5x | 5.5x |
Sat, 09 Jul 2022 | US$747.6b | US$148.1b | US$20.1b | 31.1x | 37.2x | 5x |
Mon, 06 Jun 2022 | US$756.1b | US$148.1b | US$20.1b | 31.2x | 37.6x | 5.1x |
Wed, 04 May 2022 | US$778.7b | US$151.0b | US$21.1b | 32.5x | 36.9x | 5.2x |
Fri, 01 Apr 2022 | US$882.4b | US$146.0b | US$25.4b | 36.3x | 34.8x | 6x |
Sun, 27 Feb 2022 | US$854.0b | US$146.1b | US$25.3b | 38.5x | 33.8x | 5.8x |
Tue, 25 Jan 2022 | US$836.8b | US$138.0b | US$27.3b | 40x | 30.6x | 6.1x |
Thu, 23 Dec 2021 | US$979.0b | US$138.0b | US$27.3b | 44.2x | 35.8x | 7.1x |
Sat, 20 Nov 2021 | US$972.7b | US$137.8b | US$27.1b | 47.1x | 35.9x | 7.1x |
Mon, 18 Oct 2021 | US$718.1b | US$106.0b | US$18.5b | 46.4x | 38.7x | 6.8x |
Wed, 15 Sep 2021 | US$736.8b | US$106.0b | US$18.6b | 49.9x | 39.6x | 7x |
Fri, 13 Aug 2021 | US$714.8b | US$105.8b | US$18.7b | 49.3x | 38.3x | 6.8x |
Tue, 08 Jun 2021 | US$601.2b | US$97.3b | US$17.5b | 41.5x | 34.4x | 6.2x |
37x
How does U.S. Clinical Research and Equipment compare with similar industries?
US Market | 0.56% | |
Healthcare | -0.40% | |
Life Sciences | -1.90% | |
Clinical Research and Equipment | -1.90% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
STVN Stevanato Group | US$31.79 | 9.0% +US$897.4m | 29.6% | PE54.8x | |
MEDP Medpace Holdings | US$402.75 | 3.3% +US$392.2m | 121.9% | PE43.8x | |
MTD Mettler-Toledo International | US$1.32k | 1.0% +US$265.6m | -10.8% | PE35.7x | |
BIO Bio-Rad Laboratories | US$340.52 | 1.2% +US$115.2m | -27.7% | PS3.6x | |
ILMN Illumina | US$133.80 | 0.5% +US$101.7m | -37.4% | PS4.7x |